I agree with others in that a significant financial incentive may be needed to encourage participants. I dont see how it can effect the integrity of the trial as I thought we were just trying to demonstrate the safety and effectiveness of detecting existing tutors in already diagnosed cases?
I guess the fundamental problem is trying to convince someone recently diagnosed with a potentially life threatening disease to take part in a test to "test safety", meaning the treatment not necessarily proven as safe yet. I know a few friends who have survived cancer and the common factor seems to be even with Medicare and private health insurance they win against the disease but are often out of pocket $20k plus, not including lost wages. Seems Australia is following the "terrific" usa model of insurances and soaring medical costs.
If we want these patients to endure a trial that is of no benefit and still to prove safety of the treatment then surely they need a great incentive. If they are not being offered a significant reward something is very wrong.
another approach is to trial pre diagnosis on suspected patients? Surely they have much more motivation to find out if it works?
also. Is the trial phase 1 just to demonstrate safety? If so why do they even need recent diagnosed patients.
- Forums
- ASX - By Stock
- IBX
- Ann: Appendix 4C - quarterly
IBX
imagion biosystems limited
Add to My Watchlist
8.33%
!
1.1¢

Ann: Appendix 4C - quarterly, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $2.214M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $1.796K | 158.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1508101 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 85335 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1508101 | 0.011 |
13 | 2335039 | 0.010 |
6 | 933318 | 0.009 |
5 | 850749 | 0.008 |
2 | 628570 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 85335 | 1 |
0.013 | 2895531 | 2 |
0.014 | 221499 | 2 |
0.015 | 567754 | 3 |
0.016 | 275757 | 3 |
Last trade - 14.49pm 04/07/2025 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online